|
1
|
Farid M, Demicco EG, Garcia R, Ahn L,
Merola PR, Cioffi A and Maki RG: Malignant peripheral nerve sheath
tumors. Oncologist. 19:193–201. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grobmyer SR, Reith JD, Shahlaee A, Bush CH
and Hochwald SN: Malignant peripheral nerve sheath tumor: Molecular
pathogenesis and current management considerations. J Surg Oncol.
97:340–349. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cashen DV, Parisien RC, Raskin K, Hornicek
FJ, Gebhardt MC and Mankin HJ: Survival data for patients with
malignant schwannoma. Clin Orthop Relat Res. 426:69–73. 2004.
View Article : Google Scholar
|
|
4
|
Kawamura T, Nomura M, Tojo H, Fujii K,
Hamasaki H, Mikami S, Bando Y, Kato H and Nishimura T: Proteomic
analysis of laser-microdissected paraffin-embedded tissues: (1)
Stage-related protein candidates upon non-metastatic lung
adenocarcinoma. J Proteomics. 73:1089–1099. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Addis MF, Tanca A, Pagnozzi D, Crobu S,
Fanciulli G, Cossu-Rocca P and Uzzau S: Generation of high-quality
protein extracts from formalin-fixed, paraffin-embedded tissues.
Proteomics. 9:3815–3823. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tanca A, Addis MF, Pagnozzi D, Cossu-Rocca
P, Tonelli R, Falchi G, Eccher A, Roggio T, Fanciulli G and Uzzau
S: Proteomic analysis of formalin-fixed, paraffin-embedded lung
neuroendocrine tumor samples from hospital archives. J Proteomics.
74:359–370. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang SK, Darfler MM, Nicholl MB, You J,
Bemis KG, Tegeler TJ, Wang M, Wery JP, Chong KK, Nguyen L, Scolyer
RA and Hoon DS: LC/MS-based quantitative proteomic analysis of
paraffin-embedded archival melanomas reveals potential proteomic
biomarkers associated with metastasis. PLoS One. 4:e44302009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Götz S, García-Gómez JM, Terol J, Williams
TD, Nagaraj SH, Nueda MJ, Robles M, Talón M, Dopazo J and Conesa A:
High-throughput functional annotation and data mining with the
Blast2GO suite. Nucleic Acids Res. 36:3420–3435. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kanehisa M, Goto S, Sato Y, Furumichi M
and Tanabe M: KEGG for integration and interpretation of
large-scale molecular data sets. Nucleic Acids Res. 40:D109–D114.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Endo M, Kobayashi C, Setsu N, Takahashi Y,
Kohashi K, Yamamoto H, Tamiya S, Matsuda S, Iwamoto Y, Tsuneyoshi M
and Oda Y: Prognostic significance of p14ARF, p15INK4b, and
p16INK4a inactivation in malignant peripheral nerve sheath tumors.
Clin Cancer Res. 17:3771–3782. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bradtmöller M, Hartmann C, Zietsch J,
Jäschke S, Mautner VF, Kurtz A, Park SJ, Baier M, Harder A, Reuss
D, et al: Impaired Pten expression in human malignant peripheral
nerve sheath tumours. PLoS One. 7:e475952012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alaggio R, Turrini R, Boldrin D, Merlo A,
Gambini C, Ferrari A, Dall'igna P, Coffin CM, Martines A, Bonaldi
L, et al: Survivin expression and prognostic significance in
pediatric malignant peripheral nerve sheath tumors (MPNST). PLoS
One. 8:e804562013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fan Q, Yang J and Wang G: Clinical and
molecular prognostic predictors of malignant peripheral nerve
sheath tumor. Clin Transl Oncol. 16:191–199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ikuta K, Urakawa H, Kozawa E, Arai E, Zhuo
L, Futamura N, Hamada S, Kimata K, Ishiguro N and Nishida Y:
Hyaluronan expression as a significant prognostic factor in
patients with malignant peripheral nerve sheath tumors. Clin Exp
Metastasis. 31:715–725. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang T, Yin H, Han S, Yang X, Wang J,
Huang Q, Yan W, Zhou W and Xiao J: Malignant peripheral nerve
sheath tumor (MPNST) in the spine: A retrospective analysis of
clinical and molecular prognostic factors. J Neurooncol.
122:349–355. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kolberg M, Høland M, Lind GE, Ågesen TH,
Skotheim RI, Hall KS, Mandahl N, Smeland S, Mertens F, Davidson B
and Lothe RA: Protein expression of BIRC5, TK1, and TOP2A in
malignant peripheral nerve sheath tumours - A prognostic test after
surgical resection. Mol Oncol. 9:1129–1139. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shintani K, Matsumine A, Kusuzaki K,
Morikawa J, Matsubara T, Wakabayashi T, Araki K, Satonaka H,
Wakabayashi H, Iino T and Uchida A: Decorin suppresses lung
metastases of murine osteosarcoma. Oncol Rep. 19:1533–1539.
2008.PubMed/NCBI
|
|
18
|
Biaoxue R, Xiguang C, Hua L, Hui M,
Shuanying Y, Wei Z, Wenli S and Jie D: Decreased expression of
decorin and p57(KIP2) correlates with poor survival and lymphatic
metastasis in lung cancer patients. Int J Biol Markers. 26:9–21.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Araki K, Wakabayashi H, Shintani K,
Morikawa J, Matsumine A, Kusuzaki K, Sudo A and Uchida A: Decorin
suppresses bone metastasis in a breast cancer cell line. Oncology.
77:92–99. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miyasaka Y, Enomoto N, Nagayama K, Izumi
N, Marumo F, Watanabe M and Sato C: Analysis of differentially
expressed genes in human hepatocellular carcinoma using suppression
subtractive hybridization. Br J Cancer. 85:228–234. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Köninger J, Giese NA, di Mola FF, Berberat
P, Giese T, Esposito I, Bachem MG, Büchler MW and Friess H:
Overexpressed decorin in pancreatic cancer: Potential tumor growth
inhibition and attenuation of chemotherapeutic action. Clin Cancer
Res. 10:4776–4783. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nyman MC, Sainio AO, Pennanen MM, Lund RJ,
Vuorikoski S, Sundström JT and Järveläinen HT: Decorin in human
colon cancer: Localization in vivo and effect on cancer cell
behavior in vitro. J Histochem Cytochem. 63:710–720. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
El Behi M, Krumeich S, Lodillinsky C,
Kamoun A, Tibaldi L, Sugano G, De Reynies A, Chapeaublanc E,
Laplanche A, Lebret T, et al: An essential role for decorin in
bladder cancer invasiveness. EMBO Mol Med. 5:1835–1851. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu W, Neill T, Yang Y, Hu Z, Cleveland E,
Wu Y, Hutten R, Xiao X, Stock SR, Shevrin D, et al: The systemic
delivery of an oncolytic adenovirus expressing decorin inhibits
bone metastasis in a mouse model of human prostate cancer. Gene
Ther. 22:247–256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nayak S, Goel MM, Bhatia V, Chandra S,
Makker A, Kumar S, Agrawal SP, Mehrotra D and Rath SK: Molecular
and phenotypic expression of decorin as modulator of angiogenesis
in human potentially malignant oral lesions and oral squamous cell
carcinomas. Indian J Pathol Microbiol. 56:204–210. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Salomäki HH, Sainio AO, Söderström M,
Pakkanen S, Laine J and Järveläinen HT: Differential expression of
decorin by human malignant and benign vascular tumors. J Histochem
Cytochem. 56:639–646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cates JM, Memoli VA and Gonzalez RS: Cell
cycle and apoptosis regulatory proteins, proliferative markers,
cell signaling molecules, CD209, and decorin immunoreactivity in
low-grade myxofibrosarcoma and myxoma. Virchows Arch. 467:211–216.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matsumine A, Shintani K, Kusuzaki K,
Matsubara T, Satonaka H, Wakabayashi T, Iino T and Uchida A:
Expression of decorin, a small leucine-rich proteoglycan, as a
prognostic factor in soft tissue tumors. J Surg Oncol. 96:411–418.
2007. View Article : Google Scholar : PubMed/NCBI
|
